Tsumura & Co. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 4,272 full-time employees. The firm operates the Pharmaceuticals segment. In Japan, the Company conducts the manufacturing, sales, transportation and storage of prescription drugs and over-the-counter drugs, and cultivation, procurement, selection, processing and storage of raw medicinal herbs. In China, the Company is engaged in regional management, business management, production and sales of herbal extract powders, cultivation, procurement, selection, processing and storage of herbal ingredients, and sales of pharmaceuticals and food products. In Laos, the Company is engaged in cultivation, procurement, selection, processing and storage of herbal ingredients. In the United States, the Company is engaged in pharmaceutical development business.
Follow-Up Questions
Who is the CEO of Tsumura & Co?
Mr. Terukazu Kato is the President of Tsumura & Co, joining the firm since 2011.
What is the price performance of TSMRF stock?
The current price of TSMRF is $23.2, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Tsumura & Co?
Tsumura & Co belongs to Pharmaceuticals industry and the sector is Health Care
What is Tsumura & Co market cap?
Tsumura & Co's current market cap is $1.7B
Is Tsumura & Co a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Tsumura & Co, including 1 strong buy, 4 buy, 5 hold, 0 sell, and 1 strong sell
